The main message is that GLP-1 therapy behaves more like a long-term risk-reduction treatment than a short-term fix, said Robert Glatter, MD, attending physician in the Department of Emergency Medicine at Lenox Hill Hospital in New York City, and assistant professor of Emergency Medicine at Zucker School of Medicine at Hofstra/ Northwell, in a previous interview
GLP-1 users report steady, consistent weight loss that motivates you to keep going
Acute drug studies Leptin
Research indicates retatrutide may help reduce liver fat and improve lipid profiles, preventing complications such as fatty liver disease
The active ingredient in Ozempic, semaglutide, works by inducing a feeling of fullness in users, which cuts down on their appetite
Finally, since semaglutide can help with both weight loss and blood sugar control, sticking with the medication could also improve other health outcomes, like reducing the risk of type 2 diabetes and heart disease